Tempest Therapeutics Inc (NASDAQ: TPST) is -36.40% lower on its value in year-to-date trading and has touched a low of $5.35 and a high of $39.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TPST stock was last observed hovering at around $6.85 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $6.90, the stock is -1.17% and -1.16% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.14 million and changing 0.73% at the moment leaves the stock -38.96% off its SMA200. TPST registered -81.70% loss for a year compared to 6-month loss of -33.65%.
The stock witnessed a 3.60% gain in the last 1 month and extending the period to 3 months gives it a -35.45%, and is -7.63% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.84% over the week and 6.82% over the month.
Tempest Therapeutics Inc (TPST) has around 25 employees, a market worth around $28.20M and $0.00M in sales. Distance from 52-week low is 28.98% and -82.31% from its 52-week high. The company has generated returns on investments over the last 12 months (-235.95%).
The EPS is expected to grow by 48.05% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
The shares outstanding are 4.09M, and float is at 3.74M with Short Float at 2.97%.
The top institutional shareholder in the company is BLACKROCK INC. with over 0.55 million shares valued at $1.21 million. The investor’s holdings represent 2.4405 of the TPST Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 0.43 million shares valued at $0.95 million to account for 1.9157 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 0.18 million shares representing 0.7815 and valued at over $0.39 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.6841 of the shares totaling 0.15 million with a market value of $0.34 million.
Tempest Therapeutics Inc (TPST) Insider Activity
Tempest Therapeutics Inc disclosed in a document filed with the SEC on Aug 08 ’24 that Versant Venture Capital VI, L. (10% Owner) sold a total of 400,000 shares of the company’s common stock. The trade occurred on Aug 08 ’24 and was made at $1.35 per share for $0.54 million. Following the transaction, the insider now directly holds 0.6 million shares of the TPST stock.
Still, SEC filings show that on Aug 12 ’24, Versant Venture Capital VI, L. (10% Owner) disposed off 387,999 shares at an average price of $1.10 for $0.43 million. The insider now directly holds 209,941 shares of Tempest Therapeutics Inc (TPST).
